Optical Brain-Computer Interface

While traditional electrophysiological methods have shown promising results over the years, optical brain-computer interfaces that use light to interact with neurons offer several advantages, including cell-type specificity, low crosstalk bidirectionality, and highly scalable interfacing channels with high spatiotemporal resolution over large fields of view. Genetically Encoded Calcium and Voltage Indicators (GECIs and GEVIs) enable imaging of neural activity with cellular and subcellular resolution, while light-sensitive opsins allow precise temporal control of neural stimulation or inhibition. Combining these tools allows for all-optical interrogation of neural circuits by simultaneously monitoring and manipulating neural activity with unprecedented precision, paving the way for new neuroscientific discoveries and therapeutic applications.

Despite these powerful capabilities, current optical imaging techniques have several limitations. While fMRI and fNIRS struggle with resolution, multiphoton microscopes face depth constraints, and invasive miniature microscopes (e.g. GRIN lens endoscopy) lack volumetric efficiency and scalability. These setups significantly limit natural movement and behavior, constraining the types of experiments that can be conducted. There is a strong incentive to miniaturize these bulky systems to enable more naturalistic experiments and expand the range of possible applications, eventually leading the path to human translation.

To address these challenges, our group leverages integrated neurophotonics by combining highly scalable CMOS technology with advanced in-house fabrication methods. This approach enables the development of volumetrically efficient, high-resolution fluorescence microscopy solutions. We are working on developing ultrathin, wireless, miniaturized subdural CMOS optical probes (SCOPe) for bidirectional interfacing. We’ve successfully created fully wireless and subdurally implantable devices less than 200 µm in thickness that span multiple brain regions. This technology has potential applications in diagnosing and treating neurological disorders, aiding neurorehabilitation, developing prosthetics and assistive devices, and advancing fundamental neuroscience research.

Fluorescence imaging of neural activity in the deep brain has been limited by photon absorption and scattering in the brain tissue. To overcome the limitations of surface devices, we’ve developed Acus, an implantable probe capable of penetrating deep brain tissue with minimal invasiveness. This needle-like CMOS imager features monolithically integrated light sources, filters, and photodetectors in a sub-100-µm form factor to interrogate neural populations at arbitrary depths. Its large field of view enables measurements across multiple cortical layers, while its proximity to neurons allows for single-cell-resolution imaging, effectively addressing the challenge of photon scattering in deep brain tissue. Operating at 400 frames per second, the Acus device can detect single action potentials of individual neurons in specific neural subpopulations by leveraging the recent advancements in optogenetics.